OPA1 is an important mitochondrial quality control gene and heterozygous mutations in this gene result in dominant optic atrophy (DOA), a disease specifically affecting the retinal ganglion cells and the optic nerve (Alexander et al., 2000; Delettre et al., 2000). This evidence concerns the gene OPA1 and autosomal dominant optic atrophy.